UTMB makes history with first uniportal robotic lobectomies in Texas

The University of Texas Medical Branch marks a significant breakthrough in the field of thoracic surgery as Dr. Roman Petrov, professor of the Division of Cardiothoracic Surgery, successfully performed the first robotic lobectomies in the United States with a single port of entry. “The success using this intricate surgical technique highlights our commitment to advancing patient care through a cutting-edge approach,” said Petrov. Traditionally, lung resection for cancer is performed via multi portal robotic-assisted thoracoscopic...

In pursuit of accuracy: A novel approach to incorporating clinical complexity in centralized ambulatory patient scheduling

BY Ayal Bitton, Advisory Managing Director, and Alex Obenauf, Advisory Managing Director, Customer and Operations Health & Government, KPMG   For many provider organizations, one of the most challenging aspects of centralizing patient scheduling is systematizing accurate appointment scheduling. In decentralized (practice) settings, providers’ diverse preferences for how, when and how long a patient ought to be scheduled are often accommodated by localized knowledge and proximity to providers. The scheduling of the same service within...

Patients with coronary artery disease (CAD) are benefiting from an advanced technology that can accurately model blood flow to the heart and reduce the need for invasive procedures. The HeartFlow® Analysis uses data gathered during a routine CT scan to create a computerized, color-coded, 3D model of the patient’s heart and associated blood flow, giving physicians a detailed look at both the location of artery blockages and their exact impact on the heart. In the...

New technology reduces chemotherapy-related hair loss for patients at Houston Methodist Sugar Land Hospital

For patients undergoing chemotherapy to treat cancer, hair loss can be a devastating side effect. But now a proven technology – available to Houston Methodist Sugar Land Hospital patients – can help reduce or even eliminate the hair loss known as chemotherapy-induced alopecia (CIA). The Paxman Scalp Cooling System was approved by the FDA in 2017 and is now cleared for use on patients who are undergoing chemotherapy to treat solid-tumor cancers such as ovarian,...

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives